Cel-Sci Corporation (NYSE AMERICAN: CVM)
$1.49
+0.1750 ( +13.36% ) 719.1K
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Market Data
Open
$1.49
Previous close
$1.31
Volume
719.1K
Market cap
$81.24M
Day range
$1.31 - $1.59
52 week range
$1.04 - $3.23
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 4 | Mar 07, 2024 |
10-q | Quarterly Reports | 58 | Feb 14, 2024 |
8-k | 8K-related | 23 | Feb 13, 2024 |
4 | Insider transactions | 1 | Jan 02, 2024 |
4 | Insider transactions | 1 | Jan 02, 2024 |
4 | Insider transactions | 1 | Jan 02, 2024 |
10-k | Annual reports | 86 | Dec 21, 2023 |
8-k | 8K-related | 22 | Nov 20, 2023 |
8-k | 8K-related | 34 | Oct 30, 2023 |
8-k | 8K-related | 18 | Oct 24, 2023 |